Greetings, and welcome to the Erasca Corporate Update Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Jonathan Lim, CEO and Chairman.

Robust monotherapy efficacy in KRAS G12X NSCLC: 62% uORR in 2L+ and 75% uORR in post-ICI/platinum 2/3L at 16-32 mg QD PAD, and 64% uORR in 2L+ at 24-32 mg QD RDE Robust monotherapy efficacy in 2L KRAS ...

SAN DIEGO - Erasca, Inc. (NASDAQ:ERAS) announced preliminary Phase 1 dose escalation data for ERAS-0015, an investigational pan-RAS molecular glue, in patients with RAS-mutant solid tumors, according ...

(MENAFN- GlobeNewsWire - Nasdaq) Robust monotherapy efficacy in KRAS G12X NSCLC: 62% uORR in 2L+ and 75% uORR in post-ICI/platinum 2/3L at 16-32 mg QD PAD, and 64% uORR in 2L+ at 24-32 mg QD RDE ...

Importing is attractive, and Chinese sellers know US people want it. A growing number of Americans are turning to Chinese suppliers to cut the cost of building and renovating their homes, bypassing ...

Looking at who is remaining on the Age & RAS guardrails draft board heading into day three of the NFL draft. With the first three rounds of the draft complete and heading towards the third day of the ...

Gennadiy Tsygan knows how expensive it is to build a home in the United States. That’s why he imported almost everything for his dream house from China. Most of his home fixtures were imported ...

SOUTH SAN FRANCISCO, Calif., April 21, 2026 (GLOBE NEWSWIRE)-- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway ...

Data highlight RM-055's ability to overcome resistance and provide deep, durable antitumor activity across preclinical models of pancreatic ductal adenocarcinoma, non-small cell lung cancer and ...

Faculty, students, alumni and business leaders attended business panels, ate Hotelie-made meals and drinks and toured Ithaca with Hotelie-designed itineraries during the 101st Annual Hotel Ezra ...